
- Volume 0 0
Risperidone May Treat Autism Behaviors
A recent study review concludedthat risperidone (Risperdal), generallyused to control symptoms of schizophrenia,might be beneficial for treatingautism-related behaviors, such asirritability, repetition, and hyperactivity.Because of the few studies used in thisreview, the researchers examined onlythose 3 specific symptoms.
Reviewers arrived at their conclusionsfrom 3 randomized, placebo-controlledstudies that included 211 participants,31 of whom were adults. Because thestudies reviewed were of short duration,the long-term effects of risperidonefor treating autistic behaviors arenot yet known. Researchers warn,however, that side effects, such asweight gain and involuntary musclemovements, may detract from anybenefits.
Susan Levy, MD, director of the RegionalAutism Center at The Children'sHospital in Philadelphia, Pa, noted,"The researchers seemed to be lukewarmtoward their positive findings.From personal experience, this medicationcan be quite helpful for behavioraldifficulties."She did, however,advise that expectations not be toohigh for this medication and that it is a"serious medication"for more severedifficulties. "This is not a cure for autismor the core symptoms,"she said.
Ms. Farley is a freelance medicalwriter based in Wakefield, RI.
Articles in this issue
over 18 years ago
can you READ these Rxs?over 18 years ago
compounding HOTLINEover 18 years ago
Pseudoephedrine Logs Need Constant Tendingover 18 years ago
Another Federal Court Rejects a Drug Importation Planover 18 years ago
Home Infusion Therapy Gets Patients Out of the Hospitalover 18 years ago
RESPy AWARD: Teamwork Is the Thread That Bindsover 18 years ago
Child-resistant Does Not Mean Childproofover 18 years ago
ccpa SPEAKS OUT: CCPA Works to Improve Medicare Part Dover 18 years ago
Genetic Testing: Remarkable Resource or Invasion of Privacy?over 18 years ago
case STUDIESNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.